Understanding Tobacco And Tobacco Harm Reduction: A Path Forward

      Jul 1, 2013 - Jul 1, 2013
      Intercontinental Soeul Coex, Bongeunsa-ro, Gangnam-gu, Seoul, 135-975, South Korea
      Developing and commercializing reduced risk tobacco products has been one of PMI’s top priorities for many years. Underlying the development of these products is the need for scientific validation of the risk reduction potential of such products. PMI would like to share with you how Toxicology and Systems Biology are helping the company meet this significant challenge. During the symposium, PMI scientists will present their research on Toxicology and Systems Biology approaches.